Axcelis Technologies, Inc.

Axcelis Technologies, Inc.(ACLS)股票分析

$108.350

-6.360 (-5.87%)收盤時

Loading chart…
最高
114.265
開盤
112.780
成交量加權均價
110.27
成交量
283.26K
市值
4.54B
最低
108.185
成交金額
31.23M
企業價值/稅息折舊攤銷前利潤(TTM)
29.15

Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available.

AI 分析 of Axcelis Technologies, Inc. (ACLS)

持有

Axcelis Technologies Inc is currently a hold. The stock is priced at $134.71, which is below the higher analyst target of $198 from B. Riley, indicating potential upside. However, the recent 5-day change of -8.84% and insider selling activity increasing by 2536.94% raise concerns about short-term performance. The forward P/E ratio of 19.84 suggests reasonable valuation, but the downgrade from Craig-Hallum indicates caution in the near term.

估值指標

Axcelis Technologies, Inc.(ACLS)目前預期本益比為 19.84,5 年平均預期本益比為 19.78。

預期本益比

合理
5 年均值 P/E
19.78
目前P/E
19.84
高估
26.80
低估
12.76

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
18.10
目前EV/EBITDA
29.15
高估
34.42
低估
1.78

預期股價營收比

合理
5 年均值 P/S
3.29
目前P/S
3.38
高估
4.23
低估
2.36

Alphio AI 對 ACLS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ACLS

$45.27

情境價格

基

基準

基準 · 50%ACLS

$41.15

情境價格

悲

悲觀

悲觀 · 25%ACLS

$27.78

情境價格

持有 ACLS 的大戶

W

Weiss Asset Management, LLC

+ 持有ACLS

-4.94%

3個月報酬率

事件時間軸

2026-09-08 (ET)

08:30:00

Axcelis to Invest $35M in New Manufacturing Facility

2026-08-06 (ET)

07:30:00

Q2 Revenue Reaches $215.2M, Exceeds Expectations

07:30:00

Sees Q3 Revenue at $230M, Consensus $214.77M

2026-07-02 (ET)

12:30:00

Axcelis Stock Drops 15.1% to $151.35

2026-06-09 (ET)

10:10:00

Axcelis Stock Rises 17.6%

資訊

ACLS 常見問題 —— 由 Alphio AI 解答

Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available. It operates in the Technology sector (SPECIAL INDUSTRY MACHINERY, NEC industry).

Axcelis Technologies Inc is currently a hold. The stock is priced at $134.71, which is below the higher analyst target of $198 from B. Riley, indicating potential upside. However, the recent 5-day change of -8.84% and insider selling activity increasing by 2536.94% raise concerns about short-term performance. The forward P/E ratio of 19.84 suggests reasonable valuation, but the downgrade from Craig-Hallum indicates caution in the near term.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易